Company: VERA
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0001140361-25-012034
Chunk: 1

Company: Vera Therapeutics, Inc.
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 1
---
 4. | To indicate, on an advisory basis, the preferred frequency of stockholder advisory on the compensation of the Company’s named executive officers. |

| 5. | To conduct any other business properly brought before the Annual Meeting. |

These items of business are more fully described in the Proxy Statement referenced in this Notice. You will be able to attend the Annual Meeting, submit questions and vote during the live webcast by visiting www.virtualshareholdermeeting.com/VERA2025 and entering the 16-digit Control Number included in your Notice of Internet Availability, voting instruction form, or in the instructions that you received via email. Please refer to the additional logistical details and recommendations in the accompanying Proxy Statement. You may log-in beginning at 7:45 a.m. (Pacific Time) on Wednesday, May 14, 2025.The record date for the Annual Meeting is March 17, 2025. Only holders of record of our Class A common stock at the close of business on that date and their proxyholders may vote at the Annual Meeting or any adjournment thereof. Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting to Be Held on Wednesday, May 14, 2024 at 8:00 am PT at www.virtualshareholdermeeting.com/VERA2025. The Proxy Statement and Annual Report to stockholders are available at www.proxyvote.com. By Order of the Board of Directors Marshall Fordyce, M.D. President and Chief Executive Officer Brisbane, California April 3, 2025

| Whether or not you expect to attend the meeting, please vote over the telephone or the internet as instructed in these materials, or, if you receive a paper proxy card by mail, by completing and returning the proxy mailed to you, as promptly as possible in order to ensure your representation at the Annual Meeting. Please note, however, that if your shares of Class A common stock are held of record by a broker, bank or other nominee and you wish to vote at the Annual Meeting, you may be required to obtain a proxy issued in your name from that record holder. |

TABLE OF CONTENTS

TABLE OF CONTENTS

|                                                                                                                                     |     | Page |
| QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING                                                                        |     |    1 |
| PROPOSAL 1 ELECTION OF DIRECTORS                                                                                                    |     |    7 |
| INFORMATION REGARDING THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE                                                               |     |